{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:16:57Z","timestamp":1793193417660,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102010"],"award-info":[{"award-number":["82102010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82394434"],"award-info":[{"award-number":["82394434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Amyloid-\u03b2 (A\u03b2) PET is crucial for diagnosing and monitoring Alzheimer\u2019s disease (AD), but its high cost and radiation exposure limit its use. Deep learning techniques make it possible to generate PET from structured MRI data. In this study, we built a deep learning model to generate 3D synthetic A\u03b2 PET images from structural MRI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>The generative adversarial network with share parameters (ShareGAN) model was trained and tested with 1009 A\u03b2 PET and paired MRI images from the Alzheimer\u2019s Disease Neuroimaging Initiative database and three tertiary hospitals in China. The 3D synthetic model operates on the whole volume rather than 2D image slices, realistically reproducing minor discrepancies between neighboring image planes. ShareGAN-based PET images were evaluated using quantitative metrics and visual assessment. Pearson correlation coefficient and Bland\u2013Altman analyses were used to assess the correlation and concordance between synthetic and real PETs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>3D Synthetic PET images showed high similarity and correlation with real A\u03b2 PET in external testing sets 1 and 2 in terms of structural similarity index measure (0.898, 0.899), peak signal-to-noise ratio (34.690, 34.725), mean absolute error (0.031, 0.031), and standardized uptake value ratio (R\u2009=\u20090.758, 0.828). The diagnostic accuracy of PET positive or negative status in external testing sets 1 and 2 was 88.5% and 89.4%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MRI-based 3D synthetic A\u03b2 PET images can serve as a safe and cost-effective tool for A\u03b2 status visualization, providing PET-eligible patients with A\u03b2 PET-like imaging analysis to guide subsequent real A\u03b2 PET scans.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Amyloid-\u03b2 (A\u03b2) PET limitations (high cost, radiation, limited access) hinder early Alzheimer\u2019s disease (AD) detection. Clinical practice urgently requires a suitable supplementary method for A\u03b2 pathology assessment<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>AI-synthesized 3D Synthetic A\u03b2 PET from structural MRI demonstrated strong consistency with real PET and effectively triaged high-risk patients for confirmatory scans<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>This non-invasive, cost-effective method holds the promise of enabling wider A\u03b2 pathology screening, reduces unnecessary PET scans, and supports early intervention in resource-limited settings, while preserving diagnostic rigor for treatment decisions<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-12251-3","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:15:58Z","timestamp":1767744958000},"page":"5125-5137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["MRI-to-PET synthesis via deep learning for amyloid-\u03b2 quantification in Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Zhigeng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiao","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-7930","authenticated-orcid":false,"given":"Shaozhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"12251_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312\u2013339. https:\/\/doi.org\/10.1016\/j.cell.2019.09.001","journal-title":"Cell"},{"key":"12251_CR2","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1093\/brain\/awac199","volume":"145","author":"D Sapkota","year":"2022","unstructured":"Sapkota D, Florian C, Doherty BM et al (2022) Aqp4 stop codon readthrough facilitates amyloid-\u03b2 clearance from the brain. Brain 145:2982\u20132990. https:\/\/doi.org\/10.1093\/brain\/awac199","journal-title":"Brain"},{"key":"12251_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/brain\/awv326","volume":"139","author":"W Jagust","year":"2016","unstructured":"Jagust W (2016) Is amyloid-\u03b2 harmful to the brain? Insights from human imaging studies. Brain 139:23\u201330. https:\/\/doi.org\/10.1093\/brain\/awv326","journal-title":"Brain"},{"key":"12251_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia J, Ning Y, Chen M et al (2024) Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N Engl J Med 390:712\u2013722. https:\/\/doi.org\/10.1056\/NEJMoa2310168","journal-title":"N Engl J Med"},{"key":"12251_CR5","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG et al (2024) Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement 20:5143\u20135169. https:\/\/doi.org\/10.1002\/alz.13859","journal-title":"Alzheimers Dement"},{"key":"12251_CR6","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1111\/ejn.16332","volume":"59","author":"AA Tagmazian","year":"2024","unstructured":"Tagmazian AA, Schwarz C, Lange C, Pitk\u00e4nen E, Vuoksimaa E (2024) ArcheD, a residual neural network for prediction of cerebrospinal fluid amyloid-beta from amyloid PET images. Eur J Neurosci 59:3030\u20133044. https:\/\/doi.org\/10.1111\/ejn.16332","journal-title":"Eur J Neurosci"},{"key":"12251_CR7","doi-asserted-by":"publisher","first-page":"e70038","DOI":"10.1002\/alz.70038","volume":"21","author":"J Wang","year":"2025","unstructured":"Wang J, Huang S, Lan G et al (2025) Diagnostic accuracy of plasma p-tau217\/A\u03b242 for Alzheimer\u2019s disease in clinical and community cohorts. Alzheimers Dement 21:e70038. https:\/\/doi.org\/10.1002\/alz.70038","journal-title":"Alzheimers Dement"},{"key":"12251_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s13195-024-01469-w","volume":"16","author":"Y Niimi","year":"2024","unstructured":"Niimi Y, Janelidze S, Sato K et al (2024) Combining plasma A\u03b2 and p-tau217 improves detection of brain amyloid in non-demented elderly. Alzheimers Res Ther 16:115. https:\/\/doi.org\/10.1186\/s13195-024-01469-w","journal-title":"Alzheimers Res Ther"},{"key":"12251_CR9","doi-asserted-by":"publisher","first-page":"6094","DOI":"10.1002\/alz.14087","volume":"20","author":"T Dayarathna","year":"2024","unstructured":"Dayarathna T, Roseborough AD, Gomes J et al (2024) Nanoscale flow cytometry-based quantification of blood-based extracellular vesicle biomarkers distinguishes MCI and Alzheimer\u2019s disease. Alzheimers Dement 20:6094\u20136106. https:\/\/doi.org\/10.1002\/alz.14087","journal-title":"Alzheimers Dement"},{"key":"12251_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/s1474-4422(12)70142-4","volume":"11","author":"CM Clark","year":"2012","unstructured":"Clark CM, Pontecorvo MJ, Beach TG et al (2012) Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-\u03b2 plaques: a prospective cohort study. Lancet Neurol 11:669\u2013678. https:\/\/doi.org\/10.1016\/s1474-4422(12)70142-4","journal-title":"Lancet Neurol"},{"key":"12251_CR11","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1093\/cercor\/bhab061","volume":"31","author":"Y Ding","year":"2021","unstructured":"Ding Y, Zhao K, Che T et al (2021) Quantitative radiomic features as new biomarkers for Alzheimer\u2019s disease: an amyloid PET study. Cereb Cortex 31:3950\u20133961. https:\/\/doi.org\/10.1093\/cercor\/bhab061","journal-title":"Cereb Cortex"},{"key":"12251_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P et al (2023) Lecanemab in early Alzheimer\u2019s disease. N Engl J Med 388:9\u201321. https:\/\/doi.org\/10.1056\/NEJMoa2212948","journal-title":"N Engl J Med"},{"key":"12251_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","volume":"13","author":"CJ Swanson","year":"2021","unstructured":"Swanson CJ, Zhang Y, Dhadda S et al (2021) A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody. Alzheimers Res Ther 13:80. https:\/\/doi.org\/10.1186\/s13195-021-00813-8","journal-title":"Alzheimers Res Ther"},{"key":"12251_CR14","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1056\/NEJMoa2304430","volume":"389","author":"RJ Bateman","year":"2023","unstructured":"Bateman RJ, Smith J, Donohue MC et al (2023) Two phase 3 trials of gantenerumab in early Alzheimer\u2019s disease. N Engl J Med 389:1862\u20131876. https:\/\/doi.org\/10.1056\/NEJMoa2304430","journal-title":"N Engl J Med"},{"key":"12251_CR15","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.scib.2020.04.003","volume":"65","author":"K Zhao","year":"2020","unstructured":"Zhao K, Ding Y, Han Y et al (2020) Independent and reproducible hippocampal radiomic biomarkers for multisite Alzheimer\u2019s disease: diagnosis, longitudinal progress and biological basis. Sci Bull (Beijing) 65:1103\u20131113. https:\/\/doi.org\/10.1016\/j.scib.2020.04.003","journal-title":"Sci Bull (Beijing)"},{"key":"12251_CR16","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1002\/hbm.25115","volume":"41","author":"K Popuri","year":"2020","unstructured":"Popuri K, Ma D, Wang L, Beg MF (2020) Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer\u2019s disease into dementia score: independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases. Hum Brain Mapp 41:4127\u20134147. https:\/\/doi.org\/10.1002\/hbm.25115","journal-title":"Hum Brain Mapp"},{"key":"12251_CR17","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1007\/s00259-021-05230-5","volume":"48","author":"K Zhang","year":"2021","unstructured":"Zhang K, Mizuma H, Zhang X et al (2021) PET imaging of neural activity, \u03b2-amyloid, and tau in normal brain aging. Eur J Nucl Med Mol Imaging 48:3859\u20133871. https:\/\/doi.org\/10.1007\/s00259-021-05230-5","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12251_CR18","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1001\/jamaneurol.2013.1062","volume":"70","author":"V Dor\u00e9","year":"2013","unstructured":"Dor\u00e9 V, Villemagne VL, Bourgeat P et al (2013) Cross-sectional and longitudinal analysis of the relationship between A\u03b2 deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. JAMA Neurol 70:903\u2013911. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1062","journal-title":"JAMA Neurol"},{"key":"12251_CR19","doi-asserted-by":"publisher","first-page":"fcad192","DOI":"10.1093\/braincomms\/fcad192","volume":"5","author":"E Mak","year":"2023","unstructured":"Mak E, Zhang L, Tan CH et al (2023) Longitudinal associations between \u03b2-amyloid and cortical thickness in mild cognitive impairment. Brain Commun 5:fcad192. https:\/\/doi.org\/10.1093\/braincomms\/fcad192","journal-title":"Brain Commun"},{"key":"12251_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3233\/jad-141743","volume":"45","author":"PJ Hsu","year":"2015","unstructured":"Hsu PJ, Shou H, Benzinger T et al (2015) Amyloid burden in cognitively normal elderly is associated with preferential hippocampal subfield volume loss. J Alzheimers Dis 45:27\u201333. https:\/\/doi.org\/10.3233\/jad-141743","journal-title":"J Alzheimers Dis"},{"key":"12251_CR21","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1093\/brain\/awq187","volume":"133","author":"G Ch\u00e9telat","year":"2010","unstructured":"Ch\u00e9telat G, Villemagne VL, Pike KE et al (2010) Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain 133:3349\u20133358. https:\/\/doi.org\/10.1093\/brain\/awq187","journal-title":"Brain"},{"key":"12251_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/jad-201092","volume":"80","author":"SH Kang","year":"2021","unstructured":"Kang SH, Cheon BK, Kim JS et al (2021) Machine learning for the prediction of amyloid positivity in amnestic mild cognitive impairment. J Alzheimers Dis 80:143\u2013157. https:\/\/doi.org\/10.3233\/jad-201092","journal-title":"J Alzheimers Dis"},{"key":"12251_CR23","doi-asserted-by":"publisher","first-page":"101552","DOI":"10.1016\/j.media.2019.101552","volume":"58","author":"X Yi","year":"2019","unstructured":"Yi X, Walia E, Babyn P (2019) Generative adversarial network in medical imaging: a review. Med Image Anal 58:101552. https:\/\/doi.org\/10.1016\/j.media.2019.101552","journal-title":"Med Image Anal"},{"key":"12251_CR24","doi-asserted-by":"publisher","first-page":"119898","DOI":"10.1016\/j.neuroimage.2023.119898","volume":"269","author":"R Wang","year":"2023","unstructured":"Wang R, Bashyam V, Yang Z et al (2023) Applications of generative adversarial networks in neuroimaging and clinical neuroscience. Neuroimage 269:119898. https:\/\/doi.org\/10.1016\/j.neuroimage.2023.119898","journal-title":"Neuroimage"},{"key":"12251_CR25","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1109\/tmi.2021.3107013","volume":"41","author":"S Hu","year":"2022","unstructured":"Hu S, Lei B, Wang S, Wang Y, Feng Z, Shen Y (2022) Bidirectional mapping generative adversarial networks for brain MR to PET synthesis. IEEE Trans Med Imaging 41:145\u2013157. https:\/\/doi.org\/10.1109\/tmi.2021.3107013","journal-title":"IEEE Trans Med Imaging"},{"key":"12251_CR26","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.neunet.2023.10.040","volume":"169","author":"K Chen","year":"2024","unstructured":"Chen K, Weng Y, Hosseini AA, Dening T, Zuo G, Zhang Y (2024) A comparative study of GNN and MLP based machine learning for the diagnosis of Alzheimer\u2019s Disease involving data synthesis. Neural Netw 169:442\u2013452. https:\/\/doi.org\/10.1016\/j.neunet.2023.10.040","journal-title":"Neural Netw"},{"key":"12251_CR27","doi-asserted-by":"publisher","first-page":"103032","DOI":"10.1016\/j.media.2023.103032","volume":"91","author":"C Wang","year":"2024","unstructured":"Wang C, Piao S, Huang Z et al (2024) Joint learning framework of cross-modal synthesis and diagnosis for Alzheimer\u2019s disease by mining underlying shared modality information. Med Image Anal 91:103032. https:\/\/doi.org\/10.1016\/j.media.2023.103032","journal-title":"Med Image Anal"},{"key":"12251_CR28","doi-asserted-by":"publisher","first-page":"106676","DOI":"10.1016\/j.cmpb.2022.106676","volume":"217","author":"J Zhang","year":"2022","unstructured":"Zhang J, He X, Qing L, Gao F, Wang B (2022) BPGAN: brain PET synthesis from MRI using generative adversarial network for multi-modal Alzheimer\u2019s disease diagnosis. Comput Methods Prog Biomed 217:106676. https:\/\/doi.org\/10.1016\/j.cmpb.2022.106676","journal-title":"Comput Methods Prog Biomed"},{"key":"12251_CR29","doi-asserted-by":"crossref","unstructured":"Huang G, Liu Z, Van Der Maaten L, Weinberger KQ (2017) Densely connected convolutional networks. In: Proceedings of the IEEE conference on computer vision and pattern recognition, pp 4700\u20134708","DOI":"10.1109\/CVPR.2017.243"},{"key":"12251_CR30","doi-asserted-by":"crossref","unstructured":"Huang X, Belongie S (2017) Arbitrary style transfer in real-time with adaptive instance normalization. In: Proceedings of the IEEE international conference on computer vision, pp 1501\u20131510","DOI":"10.1109\/ICCV.2017.167"},{"key":"12251_CR31","doi-asserted-by":"crossref","unstructured":"Isola P, Zhu J-Y, Zhou T, Efros AA (2017) Image-to-image translation with conditional adversarial networks. In: Proceedings of the IEEE conference on computer vision and pattern recognition, 1125\u20131134","DOI":"10.1109\/CVPR.2017.632"},{"key":"12251_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk WE, Koeppe RA, Price JC et al (2015) The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement 11:1\u201315.e11-14. https:\/\/doi.org\/10.1016\/j.jalz.2014.07.003","journal-title":"Alzheimers Dement"},{"key":"12251_CR33","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1109\/tip.2003.819861","volume":"13","author":"Z Wang","year":"2004","unstructured":"Wang Z, Bovik AC, Sheikh HR, Simoncelli EP (2004) Image quality assessment: from error visibility to structural similarity. IEEE Trans Image Process 13:600\u2013612. https:\/\/doi.org\/10.1109\/tip.2003.819861","journal-title":"IEEE Trans Image Process"},{"key":"12251_CR34","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/jmri.29070","volume":"59","author":"F Vega","year":"2024","unstructured":"Vega F, Addeh A, Ganesh A, Smith EE, MacDonald ME (2024) Image translation for estimating two-dimensional axial amyloid-beta PET from structural MRI. J Magn Reson Imaging 59:1021\u20131031. https:\/\/doi.org\/10.1002\/jmri.29070","journal-title":"J Magn Reson Imaging"},{"key":"12251_CR35","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1109\/jbhi.2024.3492020","volume":"29","author":"Z Ou","year":"2025","unstructured":"Ou Z, Pan Y, Xie F, Guo Q, Shen D (2025) Image-and-label conditioning latent diffusion model: synthesizing A\u03b2-PET from MRI for detecting amyloid status. IEEE J Biomed Health Inf 29:1221\u20131231. https:\/\/doi.org\/10.1109\/jbhi.2024.3492020","journal-title":"IEEE J Biomed Health Inf"},{"key":"12251_CR36","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1038\/s41380-022-01675-8","volume":"27","author":"AA Tsiknia","year":"2022","unstructured":"Tsiknia AA, Edland SD, Sundermann EE et al (2022) Sex differences in plasma p-tau181 associations with Alzheimer\u2019s disease biomarkers, cognitive decline, and clinical progression. Mol Psychiatry 27:4314\u20134322. https:\/\/doi.org\/10.1038\/s41380-022-01675-8","journal-title":"Mol Psychiatry"},{"key":"12251_CR37","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jamaneurol.2018.4693","volume":"76","author":"RF Buckley","year":"2019","unstructured":"Buckley RF, Mormino EC, Rabin JS et al (2019) Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol 76:542\u2013551. https:\/\/doi.org\/10.1001\/jamaneurol.2018.4693","journal-title":"JAMA Neurol"},{"key":"12251_CR38","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1093\/brain\/awab160","volume":"144","author":"S Yan","year":"2021","unstructured":"Yan S, Zheng C, Paranjpe MD et al (2021) Sex modifies APOE \u03b54 dose effect on brain tau deposition in cognitively impaired individuals. Brain 144:3201\u20133211. https:\/\/doi.org\/10.1093\/brain\/awab160","journal-title":"Brain"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12251-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12251-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:25:45Z","timestamp":1779798345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12251-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["12251"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12251-3","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Shaozhen Yan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"H.X. and S.W. are affiliated with YIWEI Medical Technology. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Two of the authors (Huanhui Xiao, Silun Wang) have significant statistical expertise.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No study subjects or cohorts have been previously reported.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}